Cryogenic CMOS Control-Silicon Adviser — Quantum Computing

The mandate

The board’s standing question is whether moving waveform generation, multiplexing and readout support into cryogenic CMOS will relieve wiring and latency constraints without consuming an impossible thermal budget or degrading qubit fidelity. Prototype chips report attractive channel density at temperatures and duty cycles unlike the target refrigerator stage. Directors need an investment path that counts calibration, variability, packaging and foundry portability rather than treating cold transistor operation as system readiness.

The adviser contributes four days monthly, attends quarterly Toronto board sessions and joins the scheduled Waterloo, Albany and Delft reviews. Each month, one claimed scaling benefit is reconstructed from transistor characterisation through circuit, package, thermal stage, control sequence and qubit consequence. Written counsel is available within three working days before a tape-out or capital gate, without assuming programme or design authority.

The appointment lasts ten months and may renew once for two months if a foundry lot or cryogenic demonstration moves beyond the planned calendar. Renewal requires a committee minute naming the residual decision, limited cadence and refreshed conflicts. It cannot become continuing circuit leadership, foundry management or laboratory operations after the investment roadmap has accountable internal owners.

The adviser has no line authority and accepts no executive responsibility for circuit design, qubit architecture, tape-out, foundry selection or capital. Engineering and the board retain those decisions. The adviser may challenge power and fidelity assumptions, recommend staged prototypes and expose irreversible dependencies, but cannot approve schematics, release masks, direct researchers or represent performance to investors or customers.

Conflicts include quantum hardware companies, cryogenic-control startups, CMOS foundries, RF and packaging suppliers, research laboratories, patents and investment funds. Employment, board seats, equity, licensing income, grants and paid technical evaluations must be disclosed. A new engagement with a proposed foundry or controller vendor during the term requires committee review and may require recusal.

Why the board wants this voice

Cryogenic CMOS promises integration but shifts problems among heat, noise, channel density, calibration and manufacturing variation. Internal researchers may optimise a favourite temperature stage or qubit modality, while foundry data rarely represents the complete control duty. Independent counsel helps the board fund experiments that reveal system consequence before a proprietary silicon path becomes difficult to reverse.

What you will own

• Challenge transistor and circuit claims across temperature, bias, variability, ageing, noise, duty cycle and model validity.
• Translate control functions into channel count, waveform fidelity, readout performance, latency, data movement and calibration burden.
• Reconstruct refrigerator heat budgets by stage, wiring reduction, static power, dynamic activity and thermal-path uncertainty.
• Compare room-temperature, intermediate-stage and near-qubit partition options through performance, serviceability and foundry constraints.
• Advise prototype gates using measured qubit impact, package evidence, model correlation and reproducible cold operation.
• Stress foundry portability, design-kit maturity, test access, packaging yield and intellectual-property dependence against scale claims.
• Leave the board a decision tree, thermal ledger, prototype sequence, vendor conflicts and capital stop conditions.

Candidate qualifications

• Advised cryogenic CMOS, RF control silicon or mixed-signal hardware programmes connected to operating quantum devices.
• Can evidence a control-integration thesis changed after complete thermal or qubit-fidelity accounting.
• Understands low-temperature transistor behaviour, mixed-signal circuits, RF control, packaging, calibration and refrigerator stages.
• Has evaluated foundry models and silicon data without extrapolating beyond measured temperature and operating conditions.
• Translated research uncertainty into staged tape-out and capital choices for boards or investment committees.
• Maintained independence amid quantum equity, foundry relationships, patents, grants and specialist control vendors.

Non-negotiables

• Will attend Toronto, Waterloo, Albany and Delft sessions in the published advisory calendar.
• Holds no undisclosed patent, equity or paid role tied to a proposed cryogenic-control architecture.
• Accepts no authority to design circuits, select foundries, release masks, direct experiments or commit capital.
• Brings direct cold-silicon and quantum-control judgment beyond general semiconductor or quantum strategy.

1. 49 words maximum. Which cryogenic-control benefit disappeared after you completed the thermal budget?
2. 49 words maximum. How would you decide which control function belongs at each refrigerator stage?
3. 49 words maximum. Which foundry, quantum, patent or investment interest could require your recusal?